Concr Launches VISION Trial Using Digital Twins for Predicting Breast Cancer Outcomes
Concr has initiated the recruitment of patients for the VISION trial, an observational clinical study designed to evaluate Concr's predictive …
All Posts
Advances in LBP Manufacturing: Microbiotica and Biose Industrie Prepare for Clinical Studies
Microbiotica, a biotechnology firm focused on developing precision microbiome medicines known as live biotherapeutic products (LBPs), is preparing for clinical …
Biostate AI Launches RNA Sequencing and Data Analysis Services
Biostate AI, a startup focused on scalable biodata solutions, has launched two new service products aimed at advancing multiomic data …
Light-weight Microscope Captures Large-scale Brain Activity in Freely Moving Mice
Researchers at Rockefeller University have developed a new lightweight microscope capable of capturing large-scale brain activity in mice while they …
Myricx Bio Secures £90m Series A Funding to Progress NMTi-ADC Therapeutics into Clinical Trials
Myricx Bio, a UK-based biotechnology company specializing in novel antibody-drug conjugates (ADCs), has raised £90 million ($114 million) in a …
FDA Approves Signet Therapeutics' IND Application for sigx1094 in Diffuse Gastric Cancer
Signet Therapeutics, a biotechnology company specializing in targeted cancer therapy, has received FDA approval for its Investigational New Drug (IND) …
OMNY Health Partners with QuantHealth and ArisGlobal to Enhance AI-Driven Healthcare Solutions
OMNY Health, a healthcare ecosystem specializing in compliant cross-industry data sharing, has launched a platform designed to support AI-driven health …
Aptamer Group Partners with AstraZeneca to Explore Optimer Vehicles for siRNA Delivery
Aptamer Group, a developer of novel Optimer® binders for the life sciences industry, has entered into an agreement with AstraZeneca …
Waypoint Bio Secures $14.5 Million to Advance Drug Discovery with Innovative In Vivo Spatial Pooled Screening Technology
Waypoint Bio, a biotechnology company focused on developing novel cell therapies for solid tumors, has raised $14.5 million in seed …
A Booming Anti-Obesity Drug Discovery Landscape at a Glance (With Challenges)
In 1986, Danish scientist Jens Juul Holst discovered that the gut hormone GLP-1 stimulates insulin and suppresses appetite. This research …
New DNA-Editing Technique Offers Potential for Advanced Genome Engineering
Researchers at the Arc Institute in California have identified a novel DNA-editing mechanism in bacteria, dubbed the “bridge editing” system, …
Formation Bio Secures $372 Million Series D Funding for AI-Driven Drug Development
Formation Bio, an AI-native pharmaceutical company, has raised $372 million in Series D financing, led by a16z and Sanofi. Additional …